Mizuho Medy Co.,Ltd. 4595.T

Healthcare · Drug Manufacturers - Specialty & Generic · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value
$353.86M
Market Cap
$205.86M
Margin of Safety
41.8%
Intrinsic / Market Ratio
1.72

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

415.40M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

308.67M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

337.51M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

353.86M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

353.86M USD

from the sum above

Market Cap

205.86M USD

today's price times the shares

Intrinsic Value ÷ Market Cap

1.72×

the ratio the screener ranks by; Margin of Safety +41.8% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 415.40M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)337.89M USD
+②Net Cash Today77.50M USD
+③Growth Value0 USD
=Value415.40M USD

EPV of the Operations (NOPAT over WACC)

337.89M USD

Net cash today

+77.50M USD

Growth Value

0 USD

Value

415.40M USD

①EPV (earnings power value)

337.89M USD

②Net Cash Today

77.50M USD

③Growth Value

0 USD

Market value

Market Cap205.86M USD

Today's price times the shares.

Value vs market

Margin of Safety+50.4%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 308.67M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE208.86M USD
+②Equity at Year 15, Today99.81M USD
=Value308.67M USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

208.86M USD

②Equity at Year 15, Today

99.81M USD

Market value

Market Cap205.86M USD

Today's price times the shares.

Value vs market

Margin of Safety+33.3%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 337.51M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF217.18M USD
+②Invested Capital at Year 15, Today42.83M USD
+③Net Cash Today77.50M USD
=Value337.51M USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

217.18M USD

②Invested Capital at Year 15, Today

42.83M USD

③Net Cash Today

77.50M USD

Market value

Market Cap205.86M USD

Today's price times the shares.

Value vs market

Margin of Safety+39.0%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 7.45%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.49×Market Risk Premium 6.00%= 7.45%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 8.38M USDPretax Income 30.31M USD= 27.66%

The tax the interest saves.

Interest Expense =EBIT 29.78M USD−Pretax Income 30.31M USD= —

The interest the company paid: EBIT is the profit before tax plus the interest.

No interest is read: it needs debt and an EBIT above the profit before tax, the gap between them being the interest. Without it the cost of debt takes the 4% default.

Cost of Debt 4.00% (default): with no debt or no interest read, the 4% default after tax stands for what the lenders are paid a year.

Debt Weight =Total Debt 0 USDMarket Cap + Total Debt 205.86M USD + 0 USD= 0.00%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 100.00%×Cost of Equity 7.45%+Debt Weight 0.00%×Cost of Debt 4.00%= 7.45%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 132.38M USD − Total Liabilities 19.05M USD = Book Value Today 113.33M USD

Total Debt 0 USD − Cash and Short-Term Investments 77.50M USD = Net Debt Today -77.50M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-0.0%at most 5%passes19,048,650 / 19,048,794
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets-7.1%at least -10.0%passes(12.52M USD − 21.92M USD) ÷ 132.38M USD
Price to bookMarket Cap ÷ Book Value Today1.82×at most 3×passes205.86M USD ÷ 113.33M USD
Operating marginOperating Income ÷ Revenue41.3%above 10.0%passes29.78M USD ÷ 72.06M USD
Revenue growthRevenue ÷ Revenue a Year Before − 1-1.1%above 10.0%does not pass72.06M USD / 72.87M USD
Net cash(Cash − Total Debt) ÷ Market Cap37.6%above -30%passes(77.50M USD − 0 USD) ÷ 205.86M USD
Operating efficiencyOperating Income ÷ Gross Profit59.5%above 25.0%passes29.78M USD ÷ 50.04M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

1.69K USD

Enterprise value

19.21B USD

market cap plus net debt

EV / EBITDA

4.32×

Price / book

1.74×

the provider's book

Price / earnings

9.99×

Return on equity

18.0%

the provider's, not the engine's

Profit margin

29.8%

Revenue growth

-0.2%

Analyst target, mean

1.70K USD

Analysts

1

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

132.41M77.78M72.87M72.06M

Gross profit

106.19M57.15M51.54M50.04M

Operating income

83.63M36.49M31.38M29.78M

EBITDA

operating income before depreciation and amortisation

85.03M37.87M32.84M31.48M

Pretax income

83.38M37.46M32.94M30.31M

Net income

59.03M26.71M24.06M21.92M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

59.03M26.71M24.06M21.94M

R&D

4.56M4.73M4.99M5.24M
Balance sheet, year end

Total assets

143.86M134.11M132.17M143.19M

Total liabilities

36.30M23.17M21.53M23.63M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

107.56M110.94M110.64M119.57M

Total debt

————

Cash and equivalents

65.54M71.73M71.70M69.28M

Net PP&E

fixed assets after depreciation

16.22M15.93M14.48M14.49M

Working capital

current assets less current liabilities

94.73M99.16M100.17M108.28M
Cash flow

Operating cash flow

46.49M28.25M21.35M12.52M

Capital expenditure

paid out, so below zero

-1.35M-1.90M-1.91M-1.81M

Depreciation and amortisation

1.41M1.38M1.45M1.70M

Free cash flow

operating cash flow plus capital expenditure

45.14M26.34M19.44M10.71M